Fenugreek Seed Galactomannan Aqueous and Extract Protects against Diabetic Nephropathy and Liver Damage by Targeting NF-κB and Keap1/Nrf2 Axis

This investigation was conducted to test the potential of the galactomannan (F-GAL) and aqueous extract (FS-AE) of the Fenugreek seed aqueous to prevent liver and kidney damage extracts in streptozotocin (STZ)-induced T1DM in rats. Non-diabetic and diabetic rats received the normal saline as a vehic...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsuliam, Sarah M., Albadr, Nawal A., Almaiman, Salah A., Al-Khalifah, Abdullrahman S., Alkhaldy, Noorah S., Alshammari, Ghedeir M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319613/
https://www.ncbi.nlm.nih.gov/pubmed/35878267
http://dx.doi.org/10.3390/toxics10070362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319613/
https://www.ncbi.nlm.nih.gov/pubmed/35878267
http://dx.doi.org/10.3390/toxics10070362

Ejemplares similares